ProQR Therapeutics N.V. buy Raymond James
Start price
29.10.24
/
50%
€3.19
Target price
29.10.25
€12.97
Performance (%)
-30.89%
End price
30.10.25
€2.20
Summary
This prediction ended on 30.10.25 with a price of €2.20. The BUY prediction by Raymond_James for ProQR Therapeutics N.V. performed very badly with a performance of -30.89%. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -8.726% | -8.726% | -28.602% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by Raymond_James for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $14.00 price target on the stock, up previously from $6.00.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€3.75
08.11.24
08.11.24
170.93%
09.11.24
09.11.24
